The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Abstract
New blood vessel formation (angiogenesis) is a fundamental event in the process of tumor growth and metastatic dissemination. Hence, the molecular basis of tumor angiogenesis has been of keen interest in the field of cancer research. The vascular endothelial growth factor (VEGF) pathway is well established as one of the key regulators of this process. The VEGF/VEGF-receptor axis is composed of multiple ligands and receptors with overlapping and distinct ligand-receptor binding specificities, cell-type expression, and function. Activation of the VEGF-receptor pathway triggers a network of signaling processes that promote endothelial cell growth, migration, and survival from pre-existing vasculature. In addition, VEGF mediates vessel permeability, and has been associated with malignant effusions. More recently, an important role for VEGF has emerged in mobilization of endothelial progenitor cells from the bone marrow to distant sites of neovascularization. The well-established role of VEGF in promoting tumor angiogenesis and the pathogenesis of human cancers has led to the rational design and development of agents that selectively target this pathway. Studies with various anti-VEGF/VEGF-receptor therapies have shown that these agents can potently inhibit angiogenesis and tumor growth in preclinical models. Recently, an anti-VEGF antibody (bevacizumab), when used in combination with chemotherapy, was shown to significantly improve survival and response rates in patients with metastatic colorectal cancer and thus, validate VEGF pathway inhibitors as an important new treatment modality in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Gerber, H.-P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30336 · Cited by 1,981
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Self-citationNeedleman, P., Truk, J., Jakschik, B. A., Morrison, A. R., & Lefkowith, J. B. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.000441 · Cited by 1,807
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,672
Self-citationWaltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656
Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., & Keshet, E. (1995) · Nature Medicine · doi:10.1038/nm1095-1024 · Cited by 1,604
Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis
Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., & Kolesnick, R. (2003) · Science · doi:10.1126/science.1082504 · Cited by 1,593
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration
Rafii, S., & Lyden, D. (2003) · Nature Medicine · doi:10.1038/nm0603-702 · Cited by 1,577
Dvorak, H. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.088 · Cited by 1,573
Browder, T. D., Butterfield, C., Kräling, B. M., Shi, B., Marshall, B., OʼReilly, M., & Folkman, J. (2000) · PubMed · Cited by 1,543
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., & Alitalo, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3566 · Cited by 1,423
Karkkainen, M. J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T. V., Jeltsch, M., Jackson, D. G., Talikka, M., Rauvala, H., et al. (2004) · Nature Immunology · doi:10.1038/ni1013 · Cited by 1,421
Kendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,394
Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., & Leung, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1806 · Cited by 1,365
Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A., & Marme, D. (1996) · Blood · doi:10.1182/blood.v87.8.3336.bloodjournal8783336 · Cited by 1,356
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., & Alitalo, K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,283
Vascular Endothelial Growth Factor
Ferrara, N. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179663 · Cited by 1,283
Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., & Ellis, L. M. (1995) · PubMed · Cited by 1,265
Self-citationVEGF-D promotes the metastatic spread of tumor cells via the lymphatics
Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S.-I., Kubo, H., & Achen, M. G. (2001) · Nature Medicine · doi:10.1038/84635 · Cited by 1,246
Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., & Keshet, E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5028 · Cited by 1,241
Achen, M. G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A., Wilks, A. F., Alitalo, K., & Stacker, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.548 · Cited by 1,205
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Self-citationKlement, G., Baruchel, S., Rak, J., Man, S., Clark, K., Hicklin, D. J., Bohlen, P., & Kerbel, R. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8829 · Cited by 1,168
Self-citationMolecular and biological properties of vascular endothelial growth factor
Ferrara, N. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900019 · Cited by 1,158
Park, J. E., Keller, G. A., & Ferrara, N. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.12.1317 · Cited by 1,122
Park, J. E., Chen, H. H., Winer, J., Houck, K. A., & Ferrara, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47298-5 · Cited by 1,112
The implications of angiogenesis for the biology and therapy of cancer metastasis
Fidler, I. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,098
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,068
Self-citationHiratsuka, S., Minowa, O., Kuno, J., Noda, T., & Shibuya, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9349 · Cited by 1,062
Gerber, H.-P., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13313 · Cited by 981
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
Mandriota, S. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.672 · Cited by 978
Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., & Sato, M. (1990) · PubMed · Cited by 960
VEGF is required for growth and survival in neonatal mice
Gerber, H.-P., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G.-A., Rangell, L., Wright, B. D., Radtke, F., Aguet, M., & Ferrara, N. (1999) · Development · doi:10.1242/dev.126.6.1149 · Cited by 915
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., & Goldberg, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10595 · Cited by 892
Brown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F., & van de Water, L. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1375 · Cited by 878
Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3
Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., & Alitalo, K. (1998) · Science · doi:10.1126/science.282.5390.946 · Cited by 874
Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice
Hanahan, D., Bergers, G., & Bergsland, E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9872 · Cited by 865
VEGF-receptor signal transduction
Cross, M. J., Dixelius, J., Matsumoto, T., & Claesson-Welsh, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00193-2 · Cited by 864
Regulation of angiogenesis via vascular endothelial growth factor receptors.
Veikkola, T., Karkkainen, M. J., Claesson, L., & Alitalo, K. K. (2000) · PubMed · Cited by 864
Wood, J. M., Bold, G., Buchdunger, E., Cozens, R. M., Ferrari, S. M., Frei, J., Hofmann, F., Mestan, J., Mett, H., O'Reilly, T., et al. (2000) · PubMed · Cited by 845
Loss of PTEN facilitates HIF-1-mediated gene expression
Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., et al. (2000) · Genes & Development · doi:10.1101/gad.14.4.391 · Cited by 840
The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities
Clauss, M., Weich, H., Breier, G., Knies, U., Röckl, W., Waltenberger, J., & Risau, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17629 · Cited by 836
A requirement for neuropilin-1 in embryonic vessel formation
Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T., & Fujisawa, H. (1999) · Development · doi:10.1242/dev.126.21.4895 · Cited by 827
Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Plaisance, S., De Mol, M., Bono, F., et al. (2003) · Nature Medicine · doi:10.1038/nm884 · Cited by 773
Self-citationRak, J. W., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., & Kerbel, R. S. (1995) · PubMed · Cited by 762
Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_6 · Cited by 743
Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., & Jain, R. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14765 · Cited by 719
Prewett, M. C., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K. D., Overholser, J. C., Hooper, A. T., Pytowski, B., Witte, L., et al. (1999) · PubMed · Cited by 713
Self-citationAngiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1
LeCouter, J., Moritz, D. R., Li, B., Phillips, G. L., Liang, X. H., Gerber, H.-P., Hillan, K. J., & Ferrara, N. (2003) · Science · doi:10.1126/science.1079562 · Cited by 679
Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
Rafii, S., Lyden, D., Benezra, R., Hattori, K., & Heissig, B. (2002) · Nature Reviews Cancer · doi:10.1038/nrc925 · Cited by 679
Lee, C. G., Heijn, M., di Tomaso, E., Griffon, G., Ancukiewicz, M., Koike, C., Park, K. R., Ferrara, N., Jain, R. K., Suit, H. D., et al. (2000) · PubMed · Cited by 677
Veikkola, T., Jussila, L., Makinen, T., Karpanen, T., Jeltsch, M., Petrova, T. V., Kubo, H., Thurston, G., McDonald, D. M., Achen, M. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1223 · Cited by 663
Zachary, I. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00268-6 · Cited by 662
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema
Karkkainen, M. J., Ferrell, R. E., Lawrence, E. C., Kimak, M. A., Levinson, K. L., McTigue, M. A., Alitalo, K., & Finegold, D. N. (2000) · Nature Genetics · doi:10.1038/75997 · Cited by 650
Eliceiri, B. P., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6869 · Cited by 649
Abnormal lymphatic vessel development in neuropilin 2 mutant mice
Yuan, L., Moyon, D., Pardanaud, L., Bréant, C., Karkkainen, M. J., Alitalo, K., & Eichmann, A. (2002) · Development · doi:10.1242/dev.129.20.4797 · Cited by 632
Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
Maeda, K., Chung, Y.-S., Ogawa, Y., Kang, S.-M., Ogawa, M., Sawada, T., & Sowa, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960301)77:5<858::aid-cncr8>3.0.co;2-a · Cited by 627
A model for gene therapy of human hereditary lymphedema
Karkkainen, M. J., Saaristo, A., Jussila, L., Karila, K. A., Lawrence, E. C., Pajusola, K., Bueler, H., Eichmann, A., Kauppinen, R., Kettunen, M. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221449198 · Cited by 606
Keyt, B. A., Berleau, L. T., Nguyen, H. V., Chen, H., Heinsohn, H., Vandlen, R., & Ferrara, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7788 · Cited by 604
Olofsson, B., Korpelainen, E., Pepper, M. S., Mandriota, S. J., Aase, K., Kumar, V., Gunji, Y., Jeltsch, M. M., Shibuya, M., Alitalo, K., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11709 · Cited by 560
De Palma, M., Venneri, M. A., Roca, C., & Naldini, L. (2003) · Nature Medicine · doi:10.1038/nm871 · Cited by 549
VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
Valtola, R., Salven, P., Heikkilä, P., Taipale, J., Joensuu, H., Rehn, M., Pihlajaniemi, T., Weich, H., deWaal, R., & Alitalo, K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65392-8 · Cited by 541
Shweiki, D., Itin, A., Neufeld, G., Gitay-Goren, H., & Keshet, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116450 · Cited by 532
Vascular endothelial growth factor and the regulation of angiogenesis.
Ferrara, N. (2000) · PubMed · Cited by 524
He, Y., Kozaki, K.-I., Karpanen, T., Koshikawa, K., Yla-Herttuala, S., Takahashi, T., & Alitalo, K. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.819 · Cited by 521
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
Bellamy, W. T., Richter, L., Frutiger, Y. M., & Grogan, T. M. (1999) · PubMed · Cited by 515
Matthews, W., Jordan, C. T., Gavin, M., Jenkins, N. A., Copeland, N. G., & Lemischka, I. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9026 · Cited by 501
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer
COBLEIGH, M. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.013 · Cited by 488
Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., & Dvorak, H. F. (1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9_10 · Cited by 472
Abedi, H., & Zachary, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15442 · Cited by 471
Van Belle, E., Witzenbichler, B., Chen, D., Silver, M., Chang, L., Schwall, R., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.4.381 · Cited by 445
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration
Dias, S., Hattori, K., Zhu, Z., Heissig, B., Choy, M., Lane, W., Wu, Y., Chadburn, A., Hyjek, E., Gill, M., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8978 · Cited by 434
Self-citationCongenital Hereditary Lymphedema Caused by a Mutation That Inactivates VEGFR3 Tyrosine Kinase
Irrthum, A., Karkkainen, M. J., Devriendt, K., Alitalo, K., & Vikkula, M. (2000) · The American Journal of Human Genetics · doi:10.1086/303019 · Cited by 430
Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.
Zhang, X., Gaspard, J. P., & Chung, D. C. (2001) · PubMed · Cited by 427
Bruns, C. J., Harbison, M. T., Davis, D. W., Portera, C. A., Tsan, R. Z., McConkey, D. J., Evans, D. B., Abbruzzese, J. L., Hicklin, D. J., & Radinsky, R. (2000) · PubMed · Cited by 422
Self-citationRegulation of vascular permeability by vascular endothelial growth factors
Bates, D. O., & Harper, S. J. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(03)00011-9 · Cited by 411
Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H., & Fujisawa, H. (1995) · Development · doi:10.1242/dev.121.12.4309 · Cited by 410
Gluzman-Poltorak, Z., Cohen, T., Herzog, Y., & Neufeld, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909259199 · Cited by 407
Ogawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y., & Shibuya, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31273 · Cited by 406
Vascular Endothelial Growth Factor Receptor-3 in Lymphangiogenesis in Wound Healing
Paavonen, K., Puolakkainen, P., Jussila, L., Jahkola, T., & Alitalo, K. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65021-3 · Cited by 398
Redefining the Target: Chemotherapeutics as Antiangiogenics
Miller, K. D., Sweeney, C. J., & Sledge, G. W. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1195 · Cited by 395
Rajantie, I., Ilmonen, M., Alminaite, A., Ozerdem, U., Alitalo, K., & Salven, P. (2004) · Blood · doi:10.1182/blood-2004-01-0336 · Cited by 390
Hiratsuka, S., Maru, Y., Okada, A., Seiki, M., Noda, T., & Shibuya, M. (2001) · PubMed · Cited by 388
Ciardiello, F., Bianco, R., Damiano, V., Fontanini, G., Caputo, R., Pomatico, G., Placido, S. D., Bianco, A. R., Mendelsohn, J. M., & Tortora, G. (2000) · PubMed · Cited by 378
Jain, R. K., Safabakhsh, N., Sckell, A., Chen, Y., Jiang, P., Benjamin, L., Yuan, F., & Keshet, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10820 · Cited by 374
VEGF: an update on biological and therapeutic aspects
Ferrara, N. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00153-1 · Cited by 372
Takashima, S., Kitakaze, M., Asakura, M., Asanuma, H., Sanada, S., Tashiro, F., Niwa, H., Miyazaki, J.-I., Hirota, S., Kitamura, Y., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022017899 · Cited by 372
The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis
Gately, S. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026575610124 · Cited by 359
Vascular endothelial growth factor
Ferrara, N. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00387-5 · Cited by 355
Neuropilin-1 Is a Placenta Growth Factor-2 Receptor
Migdal, M., Huppertz, B., Tessler, S., Comforti, A., Shibuya, M., Reich, R., Baumann, H., & Neufeld, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22272 · Cited by 348
Soker, S., Fidder, H., Neufeld, G., & Klagsbrun, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5761 · Cited by 343
Fan, F., Wey, J. S., McCarty, M. F., Belcheva, A., Liu, W., Bauer, T. W., Somcio, R. J., Wu, Y., Hooper, A., Hicklin, D. J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208246 · Cited by 342
Self-citationClinical Trial Designs for Cytostatic Agents: Are New Approaches Needed?
Korn, E. L., Arbuck, S. G., Pluda, J. M., Simon, R., Kaplan, R. S., & Christian, M. C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.265 · Cited by 331
Oxygen sensors and angiogenesis
Maxwell, P. H., & Ratcliffe, P. J. (2002) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2001.0287 · Cited by 329
Prognostic significance of angiogenesis in human pancreatic cancer
Ikeda, N., Adachi, M., Taki, T., Huang, C., Hashida, H., Takabayashi, A., Sho, M., Nakajima, Y., Kanehiro, H., Hisanaga, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690248 · Cited by 316
Gagnon, M. L., Bielenberg, D. R., Gechtman, Z., Miao, H.-Q., Takashima, S., Soker, S., & Klagsbrun, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040337597 · Cited by 313
The Interaction of Neuropilin-1 with Vascular Endothelial Growth Factor and Its Receptor Flt-1
Fuh, G., Garcia, K. C., & de Vos, A. M. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61431-6 · Cited by 312
Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma
Kim, E. S., Serur, A., Huang, J., Manley, C. A., McCrudden, K. W., Frischer, J. S., Soffer, S. Z., Ring, L., New, T., Zabski, S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398399 · Cited by 312
Makinen, T., Olofsson, B., Karpanen, T., Hellman, U., Soker, S., Klagsbrun, M., Eriksson, U., & Alitalo, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21217 · Cited by 310
Maity, A. M., Pore, N., Lee, J. S. H., Solomon, D., & O’Rourke, D. M. (2000) · PubMed · Cited by 302
Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor
Zachary, I. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1375 · Cited by 301
Fontanini, G., Vignati, S., Basolo, F., Bevilacqua, G., Lucchi, M., Mussi, A., Angeletti, C. A., Ciardiello, F., De Laurentiis, M., & De Placido, S. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.12.881 · Cited by 300
DiSalvo, J., Bayne, M. L., Conn, G., Kwok, P. W., Trivedi, P. G., Soderman, D. D., Palisi, T. M., Sullivan, K. A., & Thomas, K. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7717 · Cited by 297
Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor
Cao, Y., Chen, H., Zhou, L., Chiang, M.-K., Anand-Apte, B., Weatherbee, J. A., Wang, Y., Fang, F., Flanagan, J. G., & Tsang, M. L.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3154 · Cited by 295
VEGF‐null cells require PDGFR α signaling‐mediated stromal fibroblast recruitment for tumorigenesis
Dong, J., Grunstein, J., Tejada, M., Peale, F., Frantz, G., Liang, W., Bai, W., Yu, L., Kowalski, J., Liang, X., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600289 · Cited by 295
Zeng, H., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103213200 · Cited by 294
Kozin, S. V., Boucher, Y., Hicklin, D. J., Böhlen, P., Jain, R. K., & Suit, H. D. (2001) · PubMed · Cited by 291
Self-citationRak, J. W., Mitsuhashi, Y., Sheehan, C., Tamir, A., Viloria‐Petit, A., Filmus, J., Mansour, S. J., Ahn, N. G., & Kerbel, R. S. (2000) · PubMed · Cited by 288
Adhesion events in angiogenesis
Eliceiri, B. P., & Cheresh, D. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00252-0 · Cited by 287
Göthert, J. R., Gustin, S. E., van Eekelen, J. A. M., Schmidt, U., Hall, M. A., Jane, S. M., Green, A. R., Göttgens, B., Izon, D. J., & Begley, C. G. (2004) · Blood · doi:10.1182/blood-2003-11-3952 · Cited by 285
Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation
Meadows, K. N., Bryant, P., & Pumiglia, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108069200 · Cited by 278
Costa, C., Soares, R., Reis-Filho, J. S., Leitao, D., Amendoeira, I., & Schmitt, F. C. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.6.429 · Cited by 275
Warren, R. S., Yuan, H., Matli, M. R., Ferrara, N., & Donner, D. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29483 · Cited by 274
Jakeman, L. B. (1993) · Endocrinology · doi:10.1210/en.133.2.848 · Cited by 274
Dias, S., Hattori, K., Heissig, B., Zhu, Z., Wu, Y., Witte, L., Hicklin, D. J., Tateno, M., Bohlen, P., Moore, M. A. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191117498 · Cited by 268
Self-citationOkada, F., Rak, J. W., Croix, B. S., Lieubeau, B., Kaya, M., Roncari, L., Shirasawa, S., Sasazuki, T., & Kerbel, R. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3609 · Cited by 267
Markedly Elevated Levels of Vascular Endothelial Growth Factor in Malignant Ascites
Zebrowski, B. K., Liu, W., Ramirez, K., Akagi, Y., Mills, G. B., & Ellis, L. M. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0373-0 · Cited by 254
Self-citationGerber, H., Kowalski, J., Sherman, D. A., Eberhard, D. A., & Ferrara, N. (2000) · PubMed · Cited by 251
Takahashi, Y., Cleary, K. R., Mai, M., Kitadai, Y., Bucana, C. D., & Ellis, L. M. (1996) · PubMed · Cited by 244
Self-citationPrice, D. J., Miralem, T., Jiang, S., Steinberg, R., & Avraham, H. K. (2001) · PubMed · Cited by 243
Bouvet, M., Ellis, L. M., Nishizaki, M., Fujiwara, T., Liu, W., Bucana, C. D., Fang, B., Lee, J. J., & Roth, J. A. (1998) · PubMed · Cited by 242
Self-citationSemaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors
Takahashi, T., Nakamura, F., Jin, Z., Kalb, R. G., & Strittmatter, S. M. (1998) · Nature Neuroscience · doi:10.1038/2203 · Cited by 239
Kerbel, R. S., Yu, J., Tran, J., Man, S., Viloria-Petit, A., Klement, G., Coomber, B. L., & Rak, J. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013172910858 · Cited by 237
The Role of Phosphatidylinositol 3-Kinase in Vascular Endothelial Growth Factor Signaling
Thakker, G. D., Hajjar, D. P., Muller, W. A., & Rosengart, T. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10002 · Cited by 236
Shaheen, R. M., Ahmad, S. A., Liu, W., Reinmuth, N., Jung, Y. D., Tseng, W. W., Drazan, K. E., Bucana, C. D., Hicklin, D. J., & Ellis, L. M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1936 · Cited by 235
Self-citationCao, R., Bråkenhielm, E., Li, X., Pietras, K., Widenfalk, J., Östman, A., Eriksson, U., & Cao, Y. (2002) · The FASEB Journal · doi:10.1096/fj.02-0319com · Cited by 229
Huang, J., Frischer, J. S., Serur, A., Kadenhe, A., Yokoi, A., McCrudden, K. W., New, T., O'Toole, K., Zabski, S., Rudge, J. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432908100 · Cited by 227
Zebrowski, B. K., Yano, S., Liu, W., Shaheen, R. M., Hicklin, D. J., Putnam, J. B., & Ellis, L. M. (1999) · PubMed · Cited by 223
Self-citationFractal Characteristics of Tumor Vascular Architecture During Tumor Growth and Regression
Gazit, Y., Baish, J. W., Safabakhsh, N., Leunig, M., Baxter, L. T., & Jain, R. K. (1997) · Microcirculation · doi:10.3109/10739689709146803 · Cited by 215
Reinmuth, N., Liu, W., Jung, Y. D., Ahmad, S. A., Shaheen, R. M., Fan, F., Bucana, C. D., McMahon, G., Gallick, G. E., & Ellis, L. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0693fje · Cited by 214
Self-citationYao, M., Kargman, S., Lam, E. C., Kelly, C. R., Zheng, Y., Luk, P., Kwong, E. C., Evans, J. F., & Wolfe, M. M. (2003) · PubMed · Cited by 213
The role of HER2 in angiogenesis
KUMAR, R. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90279-9 · Cited by 212
Decaussin, M., Sartelet, H., Robert, C., Moro, D., Claraz, C., Brambilla, C., & Brambilla, E. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199908)188:4<369::aid-path381>3.0.co;2-x · Cited by 212
Urokinase Plasminogen Activator System: A Multifunctional Role in Tumor Progression and Metastasis
Choong, P., & Nadesapillai, A. P. W. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo0000093845.72468.bd · Cited by 208
Regulation of distinct steps of angiogenesis by different angiogenic molecules.
Kumar, R., Yoneda, J., Bucana, C. D., & Fidler, I. J. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.4.749 · Cited by 204
Ellis, L. M., Staley, C. A., Liu, W., Fleming, R. Y. D., Parikh, N. U., Bucana, C. D., & Gallick, G. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.1052 · Cited by 203
Self-citationLymphangiogenesis and tumor metastasis
Pepper, M. S., Tille, J.-C., Nisato, R., & Skobe, M. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0748-7 · Cited by 198
Expression of vascular endothelial growth factor receptors in human prostate cancer
Ferrer, F. A., Miller, L. J., Lindquist, R., Kowalczyk, P., Laudone, V. P., Albertsen, P. C., & Kreutzer, D. L. (1999) · Urology · doi:10.1016/s0090-4295(99)00156-9 · Cited by 197
Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
McColl, B. K., Baldwin, M. E., Roufail, S., Freeman, C., Moritz, R. L., Simpson, R. J., Alitalo, K., Stacker, S. A., & Achen, M. G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030361 · Cited by 197
Pal, S., Datta, K., & Mukhopadhyay, D. (2001) · PubMed · Cited by 196
Soker, S., Gollamudi-Payne, S., Fidder, H., Charmahelli, H., & Klagsbrun, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31582 · Cited by 196
Lamszus, K., Ulbricht, U., Matschke, J., Brockmann, M. A., Fillbrandt, R., & Westphal, M. (2003) · PubMed · Cited by 189
Vascular Endothelial Growth Factor-B Promotes In Vivo Angiogenesis
Silvestre, J.-S., Tamarat, R., Ebrahimian, T. G., Le-Roux, A., Clergue, M., Emmanuel, F., Duriez, M., Schwartz, B., Branellec, D., & Lévy, B. I. (2003) · Circulation Research · doi:10.1161/01.res.0000081594.21764.44 · Cited by 188
Akagi, Y., Liu, W., Zebrowski, B. K., Xie, K., & Ellis, L. M. (1998) · PubMed · Cited by 184
Self-citationGille, H., Kowalski, J., Yu, L., Chen, H., Pisabarro, M. T., Davis-Smyth, T., & Ferrara, N. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4064 · Cited by 181
Reinmuth, N., Fan, F., Liu, W., Parikh, A. A., Stoeltzing, O., Jung, Y. D., Bucana, C. D., Radinsky, R., Gallick, G. E., & Ellis, L. M. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000032411.41603.c2 · Cited by 174
Self-citationLacal, P. M., Failla, C. M., Pagani, E., Odorisio, T., Schietroma, C., Falcinelli, S., Zambruno, G., & D'Atri, S. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00199.x · Cited by 172
Hess, C. F., Vuong, V., Hegyi, I., Riesterer, O., Wood, J. M., Fabbro, D., Glanzmann, C., Bodis, S. B., & Pruschy, M. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2166 · Cited by 171
Fujimoto, K., Hosotani, R., Wada, M., Lee, J.-U., Koshiba, T., Miyamoto, Y., Tsuji, S., Nakajima, S., Doi, R., & Imamura, M. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00069-0 · Cited by 168
Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
Choong, P., & Nadesapillai, A. P. W. (2003) · PubMed · doi:10.1097/01.blo.0000093845.72468.bd · Cited by 167
Liu, X.-H., Kirschenbaum, A., Yao, S., Stearns, M. E., Holland, J. F., Claffey, K., & Levine, A. C. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006728119549 · Cited by 162
Hu, L., Hofmann, J., Zaloudek, C., Ferrara, N., Hamilton, T., & Jaffe, R. B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64467-7 · Cited by 161
Reinmuth, N., Liu, W., Fan, F., Jung, Y. D., Ahmad, S. A., Stoeltzing, O., Bucana, C. D., Radinsky, R., & Ellis, L. M. (2002) · PubMed · Cited by 149
Self-citationBruns, C. J., Shrader, M., Harbison, M. T., Portera, C. A., Solórzano, C. C., Jauch, K. ‐., Hicklin, D. J., Radinsky, R., & Ellis, L. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10681 · Cited by 146
Self-citationVascular endothelial growth factor receptor‐2: Its unique signaling and specific ligand, VEGF‐E
Shibuya, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01514.x · Cited by 146
Akagi, M., Kawaguchi, M., Liu, W., McCarty, M. F., Takeda, A., Fan, F., Stoeltzing, O., Parikh, A. A., Jung, Y. D., Bucana, C. D., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600811 · Cited by 133
Self-citationToi, M., Bando, H., Ogawa, T., Muta, M., Hornig, C., & Weich, H. A. (2001) · International Journal of Cancer · doi:10.1002/ijc.10121 · Cited by 132
Feldkamp, M. M., Lau, N. C., Rak, J. W., Kerbel, R. S., & Guha, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990331)81:1<118::aid-ijc20>3.0.co;2-5 · Cited by 124
Eibl, G., Bruemmer, D., Okada, Y., Duffy, J. P., Law, R. E., Reber, H. A., & Hines, O. J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01079-9 · Cited by 123
Banks, R. E., Forbes, M. A., Searles, J., Pappin, D., Cañas, B., Rahman, D., Kaufmann, S. H., Walters, C., Jackson, A., Eves, P. C., et al. (1998) · Molecular Human Reproduction · doi:10.1093/molehr/4.4.377 · Cited by 121
Sweeney, P., Karashima, T., Kim, S. J., Kedar, D. J., Mian, B. M., HUANG, S. F., Baker, C. H., Fan, Z., Hicklin, D. J., Pettaway, C. A., et al. (2002) · PubMed · Cited by 120
Self-citationInoue, K., Slaton, J. W., Davis, D. W., Hicklin, D. J., McConkey, D. J., Karashima, T., Radinsky, R., & Dinney, C. P. (2000) · PubMed · Cited by 119
Self-citationSolórzano, C. C., Baker, C. H., Bruns, C. J., Killion, J. J., Ellis, L. M., Wood, J. M., & Fidler, I. J. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497801753354267 · Cited by 118
Self-citationYang, W., Klos, K. S., Yang, Y., Smith, T. L., Shi, D., & Yu, D. (2002) · Cancer · doi:10.1002/cncr.10553 · Cited by 118
Biology of angiogenesis in tumors of the gastrointestinal tract
Reinmuth, N., Parikh, A. A., Ahmad, S. A., Liu, W., Stoeltzing, O., Fan, F., Takeda, A., Akagi, M., & Ellis, L. M. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10258 · Cited by 115
Self-citationWhat do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors?
Rak, J. W., Yu, J., Kerbel, R. S., & Coomber, B. L. (2002) · PubMed · Cited by 113
Krüssel, J.-S., Casañ, E. M., Raga, F., Hirchenhain, J., Wen, Y., Huang, H. Y., Bielfeld, P., & Polan, M. L. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.5.452 · Cited by 111
Casanova, M., Larcher, F., Casanova, B., Murillas, R., Fernández‐Aceñero, M. J., Villanueva, C., Martínez‐Palacio, J., Ullrich, A., Conti, C. J., & Jorcano, J. L. (2002) · PubMed · Cited by 110
Neuropilin is a Mediator of Angiogenesis
Miao, H., & Klagsbrun, M. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026579711033 · Cited by 109
Vascular Remodeling Marks Tumors That Recur During Chronic Suppression of Angiogenesis
Huang, J., Soffer, S. Z., Kim, E. S., McCrudden, K. W., Huang, J. T., New, T. N., Manley, C. A., Middlesworth, W., O’Toole, K., Yamashiro, D. J., et al. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.36.2.1 · Cited by 101
Kedar, D. J., Baker, C. H., Killion, J. J., Dinney, C. P., & Fidler, I. J. (2002) · PubMed · Cited by 92
Cited by
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
Chinot, O. L., Wick, W., Mason, W., Henriksson, R., Saran, F., Nishikawa, R., Carpentier, A. F., Hoang-Xuan, K., Kavan, P., Cernea, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308345 · Cited by 2,557
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
Celli, J. P., Spring, B. Q., Rizvi, I., Evans, C. L., Samkoe, K. S., Verma, S., Pogue, B. W., & Hasan, T. (2010) · Chemical Reviews · doi:10.1021/cr900300p · Cited by 2,324
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 1,948
VEGF-targeted therapy: mechanisms of anti-tumour activity
Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673
Self-citation
Metadata
- Authors
- Hicklin, D. J., & Ellis, L. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-02-10
- Volume
- 23
- Issue
- 5
- Pages
- 1011-1027
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2166573361
- Cited by
- 3,007
- References
- 219
- FWCI
- 33.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.